Anti-CCP Antibodies Are Not Associated with Familial Mediterranean Fever in Childhood

Table 1

Demographic characteristics and laboratory parameters, anti-CCP levels according to gender.

	Patient group; (𝑛=126); mean ± SD median (IQR)	Control group; (𝑛=50); mean ± SD median (IQR)
Age (years)	11±4	10±4
Female/male (𝑛)	66/60	25/25
Duration of diagnosis (years)	7±4
Duration of complaints (years)	6±3
Medication* (years)	4±2
Fibrinogen (mg/dL) (150–400)	308±87
CRP (mg/dL) (0–4.99)	3.0±12.8
ESR (mm/hour)	20±15
Genetic test (𝑛):
M694V/M694V	26
M694V/other	38
Other/other	46
Negative	16
Anti-CCP(RU/mL); Female/male	0.92 (0.64–1.33)/1.10 (0.73–1.48)	1.27 (1.07–1.51)/1.07 (0.68–1.49)
P	0.107	0.193

∗Colchicine treatment.